| Literature DB >> 32589546 |
Rabia Warraich1, Lisa Amani1, Rapti Mediwake2, Hasan Tahir2,3.
Abstract
The National Institute for Health and Care Excellence guidelines advise stopping immunosuppressive drugs for confirmed or suspected COVID-19 patients with autoimmune and inflammatory disorders. This may not be in the patient's best interest, given the potential long-term consequences of not managing chronic conditions, and immunosuppression may even be protective in those affected with COVID-19.Entities:
Mesh：
Substances：
Year: 2020 PMID： 32589546 DOI： 10.12968/hmed.2020.0312
Source DB: PubMed Journal: Br J Hosp Med (Lond) ISSN： 1750-8460 Impact factor: 0.825